No Data
No Data
Oppenheimer Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $27
Express News | Nurix Therapeutics : Oppenheimer Raises Target Price to $27 From $25
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Express News | Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $27
Express News | Nurix Therapeutics Shares Are Trading Higher After Truist Securities Initiated Coverage on the Stock With a Buy Rating and Announced a Price Target of $36
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
No Data